3d
Anthropic releases Claude Opus 4.7, narrowly retaking lead for most powerful generally available LLM
Opus 4.7 utilizes an updated tokenizer that improves text processing efficiency, though it can increase the token count of ...
Finding vulnerabilities is something the industry has done well, but remediating them hasn't been. Just look at how many ...
BNTX: Reported Saturday, BioNTech And DualityBio's Trastuzumab Pamirtecan Meets Primary Endpoint With 47.9% Confirmed ORR In HER2-Expressing Recurrent Endometrial Cancer Phase 2 Trial Disclosure: All ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results